Literature DB >> 15292538

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

Peter J Weiden1, Chris Kozma, Amy Grogg, Julie Locklear.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the relationship between compliance with an antipsychotic medication regimen and risk of hospitalization in a cohort of California Medicaid patients with schizophrenia.
METHODS: Compliance behavior was estimated by using a retrospective review of California Medicaid pharmacy refill and medical claims for 4,325 outpatients for whom antipsychotics were prescribed for treatment of schizophrenia from 1999 to 2001. Compliance behavior was estimated by using four different definitions: gaps in medication therapy, medication consistency and persistence, and a medication possession ratio. Patients were followed for one year and had an average of 19.1 dispensing events. Logistic regression models using each compliance estimate were used to determine the odds of hospitalization.
RESULTS: Risk of hospitalization was significantly correlated with compliance. With all definitions, lower compliance was associated with a greater risk of hospitalization over and above any other risk factors for hospitalization. For example, the presence of any gap in medication coverage was associated with increased risk of hospitalization, including gaps as small as one to ten days (odds ratio [OR]=1.98). A gap of 11 to 30 days was associated with an OR of 2.81, and a gap of more than 30 days was associated with an OR of 3.96.
CONCLUSIONS: This study showed a direct correlation between estimated partial compliance and hospitalization risk among patients with schizophrenia across a continuum of compliance behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292538     DOI: 10.1176/appi.ps.55.8.886

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  169 in total

1.  Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent.

Authors:  Gregory A Roth; Nancy E Morden; Weiping Zhou; David J Malenka; Jonathan Skinner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

Review 2.  Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation.

Authors:  Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

3.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

4.  Implementing performance improvement and measuring psychiatric care quality.

Authors:  Geetha Jayaram
Journal:  Psychiatry (Edgmont)       Date:  2007-05

Review 5.  Urgent Psychiatric Services: A Scoping Review.

Authors:  Nadiya Sunderji; Jason Tan de Bibiana; Vicky Stergiopoulos
Journal:  Can J Psychiatry       Date:  2015-09       Impact factor: 4.356

6.  Expanding patient access to quality medication-related information: the potential of medication hotlines to improve patient adherence in schizophrenia.

Authors:  Amy R Pettit; Steven C Marcus
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-04-10       Impact factor: 4.328

7.  Planning Patient-Centered Health Homes for Medicaid Psychiatric Patients at Greatest Risk for Intensive Service Use.

Authors:  Joyce C West; Donald S Rae; Ramin Mojtabai; Farifteh F Duffy; Janet Kuramoto; Eve Moscicki; William E Narrow
Journal:  Community Ment Health J       Date:  2015-02-10

8.  Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the US.

Authors:  John Robst
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

9.  Use of depot antipsychotic medications for medication nonadherence in schizophrenia.

Authors:  Joyce C West; Steven C Marcus; Joshua Wilk; Lisa M Countis; Darrel A Regier; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-12-18       Impact factor: 9.306

10.  A Medicaid and commercial insured claims-based study to estimate improved antipsychotic medication adherence among patients with schizophrenia.

Authors:  Bruce Pyenson; Sara Goldberg; Kosuke Iwasaki; Victoria Boyarsky; Riad Dirani
Journal:  J Behav Health Serv Res       Date:  2013-04       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.